Leeder JS - Search Results

1

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.

Gaedigk A, Ingelman-Sundberg M, Miller NA, Leeder JS, Whirl-Carrillo M, Klein TE; PharmVar Steering Committee. Gaedigk A, et al. Among authors: leeder js. Clin Pharmacol Ther. 2018 Mar;103(3):399-401. doi: 10.1002/cpt.910. Epub 2017 Nov 14. Clin Pharmacol Ther. 2018. PMID: 29134625 Free PMC article.

2

Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.

Leeder JS, Riley RJ, Cook VA, Spielberg SP. Leeder JS, et al. J Pharmacol Exp Ther. 1992 Oct;263(1):360-7. J Pharmacol Exp Ther. 1992. PMID: 1403797

3

Drug metabolite toxicity assessed in human lymphocytes with a purified, reconstituted cytochrome P-450 system.

Leeder JS, Cannon M, Nakhooda A, Spielberg SP. Leeder JS, et al. J Pharmacol Exp Ther. 1988 Jun;245(3):956-62. J Pharmacol Exp Ther. 1988. PMID: 3385648

4

Epitope mapping studies with human anti-cytochrome P450 3A antibodies.

Leeder JS, Gaedigk A, Lu X, Cook VA. Leeder JS, et al. Mol Pharmacol. 1996 Feb;49(2):234-43. Mol Pharmacol. 1996. PMID: 8632755

5

Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolase.

Gaedigk A, Leeder JS, Grant DM. Gaedigk A, et al. Among authors: leeder js. DNA Cell Biol. 1997 Nov;16(11):1257-66. doi: 10.1089/dna.1997.16.1257. DNA Cell Biol. 1997. PMID: 9406998

6

Non-monooxygenase cytochromes P450 as potential human autoantigens in anticonvulsant hypersensitivity reactions.

Leeder JS, Lu X, Timsit Y, Gaedigk A. Leeder JS, et al. Pharmacogenetics. 1998 Jun;8(3):211-25. doi: 10.1097/00008571-199806000-00004. Pharmacogenetics. 1998. PMID: 9682267

7

Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype.

Henne KR, Gaedigk A, Gupta G, Leeder JS, Rettie AE. Henne KR, et al. Among authors: leeder js. J Chromatogr B Biomed Sci Appl. 1998 Jun 12;710(1-2):143-8. doi: 10.1016/s0378-4347(98)00099-1. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9686881

8

NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations.

Gaedigk A, Tyndale RF, Jurima-Romet M, Sellers EM, Grant DM, Leeder JS. Gaedigk A, et al. Among authors: leeder js. Pharmacogenetics. 1998 Aug;8(4):305-13. doi: 10.1097/00008571-199808000-00004. Pharmacogenetics. 1998. PMID: 9731717

9

Investigation of terbinafine as a CYP2D6 inhibitor in vivo.

Abdel-Rahman SM, Gotschall RR, Kauffman RE, Leeder JS, Kearns GL. Abdel-Rahman SM, et al. Among authors: leeder js. Clin Pharmacol Ther. 1999 May;65(5):465-72. doi: 10.1016/S0009-9236(99)70065-2. Clin Pharmacol Ther. 1999. PMID: 10340911 Clinical Trial.

10

High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary data.

Bradford LD, Gaedigk A, Leeder JS. Bradford LD, et al. Among authors: leeder js. Psychopharmacol Bull. 1998;34(4):797-804. Psychopharmacol Bull. 1998. PMID: 10513455 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters